Gp Act Iii Acquisition Stock Net Income
| GPAT Stock | 10.74 0.02 0.19% |
As of the 24th of January, GP Act owns the Downside Deviation of 0.2602, market risk adjusted performance of 0.3192, and Variance of 0.0209. GP Act III Acquisition technical analysis makes it possible for you to employ past data patterns with the intention to determine a pattern that calculates the direction of the firm's future prices.
Analyzing historical trends in various income statement and balance sheet accounts from GP Act's financial statements helps investors evaluate the company's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting GP Act's valuation are summarized below:GP Act III Acquisition does not at this moment have any fundamental measures for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. Is Diversified Financial Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of GP Act. If investors know GPAT will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about GP Act listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of GP Act III is measured differently than its book value, which is the value of GPAT that is recorded on the company's balance sheet. Investors also form their own opinion of GP Act's value that differs from its market value or its book value, called intrinsic value, which is GP Act's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because GP Act's market value can be influenced by many factors that don't directly affect GP Act's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between GP Act's value and its price as these two are different measures arrived at by different means. Investors typically determine if GP Act is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, GP Act's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
GP Act 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to GP Act's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of GP Act.
| 10/26/2025 |
| 01/24/2026 |
If you would invest 0.00 in GP Act on October 26, 2025 and sell it all today you would earn a total of 0.00 from holding GP Act III Acquisition or generate 0.0% return on investment in GP Act over 90 days. GP Act is related to or competes with Centurion Acquisition, Berto Acquisition, Haymaker Acquisition, Bold Eagle, Cantor Equity, Voyager Acquisition, and M3 Brigade. More
GP Act Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure GP Act's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess GP Act III Acquisition upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 0.2602 | |||
| Information Ratio | (0.45) | |||
| Maximum Drawdown | 0.9368 | |||
| Value At Risk | (0.19) | |||
| Potential Upside | 0.1878 |
GP Act Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for GP Act's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as GP Act's standard deviation. In reality, there are many statistical measures that can use GP Act historical prices to predict the future GP Act's volatility.| Risk Adjusted Performance | 0.0286 | |||
| Jensen Alpha | 0.0029 | |||
| Total Risk Alpha | (0.01) | |||
| Sortino Ratio | (0.25) | |||
| Treynor Ratio | 0.3092 |
GP Act January 24, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0286 | |||
| Market Risk Adjusted Performance | 0.3192 | |||
| Mean Deviation | 0.0815 | |||
| Downside Deviation | 0.2602 | |||
| Coefficient Of Variation | 1058.02 | |||
| Standard Deviation | 0.1447 | |||
| Variance | 0.0209 | |||
| Information Ratio | (0.45) | |||
| Jensen Alpha | 0.0029 | |||
| Total Risk Alpha | (0.01) | |||
| Sortino Ratio | (0.25) | |||
| Treynor Ratio | 0.3092 | |||
| Maximum Drawdown | 0.9368 | |||
| Value At Risk | (0.19) | |||
| Potential Upside | 0.1878 | |||
| Downside Variance | 0.0677 | |||
| Semi Variance | (0) | |||
| Expected Short fall | (0.19) | |||
| Skewness | 0.1218 | |||
| Kurtosis | 4.41 |
GP Act III Backtested Returns
Currently, GP Act III Acquisition is very steady. GP Act III retains Efficiency (Sharpe Ratio) of 0.0945, which attests that the entity had a 0.0945 % return per unit of price deviation over the last 3 months. We have found twenty-six technical indicators for GP Act, which you can use to evaluate the volatility of the firm. Please check out GP Act's Variance of 0.0209, market risk adjusted performance of 0.3192, and Downside Deviation of 0.2602 to validate if the risk estimate we provide is consistent with the expected return of 0.0137%. GP Act has a performance score of 7 on a scale of 0 to 100. The company owns a Beta (Systematic Risk) of 0.0119, which attests to not very significant fluctuations relative to the market. As returns on the market increase, GP Act's returns are expected to increase less than the market. However, during the bear market, the loss of holding GP Act is expected to be smaller as well. GP Act III today owns a risk of 0.14%. Please check out GP Act III Acquisition maximum drawdown, and the relationship between the standard deviation and expected short fall , to decide if GP Act III Acquisition will be following its current price history.
Auto-correlation | 0.02 |
Virtually no predictability
GP Act III Acquisition has virtually no predictability. Overlapping area represents the amount of predictability between GP Act time series from 26th of October 2025 to 10th of December 2025 and 10th of December 2025 to 24th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of GP Act III price movement. The serial correlation of 0.02 indicates that only 2.0% of current GP Act price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.02 | |
| Spearman Rank Test | 0.34 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, GP Act III Acquisition reported net income of 8.67 M. This is 99.32% lower than that of the Financial Services sector and 98.29% lower than that of the Financials industry. The net income for all United States stocks is 98.48% higher than that of the company.
GPAT Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses GP Act's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of GP Act could also be used in its relative valuation, which is a method of valuing GP Act by comparing valuation metrics of similar companies.GP Act is currently under evaluation in net income category among its peers.
GPAT Fundamentals
| Return On Equity | 0.0983 | ||||
| Return On Asset | -0.0014 | ||||
| Current Valuation | 386.22 M | ||||
| Shares Outstanding | 28.75 M | ||||
| Shares Owned By Institutions | 100.00 % | ||||
| Number Of Shares Shorted | 1.55 K | ||||
| Price To Book | 1.32 X | ||||
| EBITDA | 8.67 M | ||||
| Net Income | 8.67 M | ||||
| Total Debt | 400 K | ||||
| Book Value Per Share | (0.40) X | ||||
| Cash Flow From Operations | (584.72 K) | ||||
| Short Ratio | 0.56 X | ||||
| Earnings Per Share | 0.34 X | ||||
| Market Capitalization | 385.97 M | ||||
| Total Asset | 297.47 M | ||||
| Retained Earnings | (13.93 M) | ||||
| Working Capital | 43.75 K | ||||
| Net Asset | 297.47 M |
About GP Act Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze GP Act III Acquisition's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of GP Act using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of GP Act III Acquisition based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for GPAT Stock Analysis
When running GP Act's price analysis, check to measure GP Act's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GP Act is operating at the current time. Most of GP Act's value examination focuses on studying past and present price action to predict the probability of GP Act's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GP Act's price. Additionally, you may evaluate how the addition of GP Act to your portfolios can decrease your overall portfolio volatility.